Table 5 Univariate and multivariate analysis for Progression Free Survival
Univariate Analysis | Multivariate Analysis | |||
|---|---|---|---|---|
Variable | HR (95% CI) | p-value | HR (95%CI) | p-value |
Age > 65 | 1.04 (0.39–1.70) | 0.82 | NA | NA |
Male sex | 1.17 (0.44–1.90) | 0.52 | NA | NA |
G3 vs G1 G2 vs G1 | 1.87 (0.90–3.88) 1.76 (0.51–6.10) | 0.92 0.38 | NA NA | NA NA |
T3-T4 vs T1-T2 | 1.73 (0.89–3.33) | 0.11 | NA | NA |
N + ve vs N -ve | 2.16 (1.18–3.96) | 0.012 | 1.98 (1.01–3.88) | 0.046 |
RT total dose | 1.12 (0.79–1.58) | 0.52 | NA | NA |
Boost: yes vs no | 0.84 (0.32–2.18) | 0.72 | NA | NA |
OTT > 42 days | 1.18 (0.53–1.85) | 0.38 | NA | NA |
Hb | 0.57 (0.39–0.85) | 0.005 | 0.78 (0.53–1.15) | 0.12 |
Response | 5.39 (2.79–10.4) | < 0.0001 | 5.43 (2.75–10.70) | < 0.0001 |